iPad Pro Isn't for Most Users: Here's Why

3 hours ago
iPad Pro Isn't for Most Users: Here's Why

If you're eyeing Apple's latest iPad Pro, think again. Unless you're a serious content creator or power user, you probably don't need the hefty price tag associated with these high-end tablets. The standard iPad models and the iPad Air offer more than enough juice for everyday tasks and even some advanced workflows.


The iPad Pro starts at a steep $999 and $1,299 for the 11-inch and 13-inch models, respectively. Add Apple's Magic Keyboard, and you're looking at an additional $350, which is enough to buy a capable MacBook. While the Pro boasts a stunning tandem OLED screen with incredible brightness, sharpness, and color, plus fantastic speakers and a sharp webcam, these premium features come at a premium cost.


Under the hood, the M5 chip provides a modest performance boost that most users won't notice in daily apps. The real benefits shine through in AI-driven apps like Draw Things or demanding creative software like DaVinci Resolve. These are the tools for professionals crafting 3D objects in Blender or producing music, not for casual browsing or media consumption.


For most people, the iPad Air is the sweet spot, especially with iPadOS 26's enhanced multitasking. This software, which works best on the larger 13-inch displays, makes the iPad feel more like a computer. If the Air proves sufficient, you'll save a significant amount of cash that can be put to better use elsewhere.


Navigating the world of Apple Pencils can also be confusing. The Apple Pencil (USB-C) at $69 is a solid, affordable choice for note-takers without pressure sensitivity. For drawing and pressure sensitivity, the older Apple Pencil (1st gen) for $99 is still functional, but the Apple Pencil Pro for $129 is the most advanced, offering features like squeeze gestures, haptic feedback, and Find My tracking, albeit with limited compatibility for newer iPads.


15-Year-Old Ebola Vaccine Could Be Lifesaver, But Funding Delays Human Trials
Previous
15-Year-Old Ebola Vaccine Could Be Lifesaver, But Funding Delays Human Trials
Next
iPad Pro Isn't for Most Users: Here's Why
iPad Pro Isn't for Most Users: Here's Why